Medium materiality5/10
UBS raises Labcorp price target to $420
Why it may matterVerify against the original reporting
A sizable upward target revision supports a bullish view, while the target remains an analyst estimate.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raised its LH target from $380 to $420; the cited share price was $360.32, about 17% below the new target.
- Target raised about 11% to $420.
- New target implies roughly 17% upside to the cited price.
Key facts
- 01
Target: $420
- 02
Posted price: $360.32
- 03
Analyst firm: UBS
- 04
Analyst: Kevin Caliendo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.